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Abstract
Chlamydia trachomatis genital infection in women causes serious adverse reproductive
complications, and is a strong co-factor for human papilloma virus (HPV)-associated cervi-
cal epithelial carcinoma. We tested the hypothesis that Chlamydia induces epithelial-mes-
enchyme transition (EMT) involving T cell-derived TNF-alpha signaling, caspase activation,
cleavage inactivation of dicer and dysregulation of micro-RNA (miRNA) in the reproductive
epithelium; the pathologic process of EMT causes fibrosis and fertility-related epithelial dys-
function, and also provides the co-factor function for HPV-related cervical epithelial carci-
noma. Using a combination of microarrays, immunohistochemistry and proteomics, we
showed that chlamydia altered the expression of crucial miRNAs that control EMT, fibrosis
and tumorigenesis; specifically, miR-15a, miR-29b, miR-382 and MiR-429 that maintain epi-
thelial integrity were down-regulated, while miR-9, mi-R-19a, miR-22 and miR-205 that pro-
mote EMT, fibrosis and tumorigenesis were up-regulated. Chlamydia induced EMT in vitro
and in vivo, marked by the suppression of normal epithelial cell markers especially E-cad-
herin but up-regulation of mesenchymal markers of pathological EMT, including T-cadherin,
MMP9, and fibronectin. Also, Chlamydia upregulated pro-EMT regulators, including the zinc
finger E-box binding homeobox protein, ZEB1, Snail1/2, and thrombospondin1 (Thbs1), but
down-regulated anti-EMT and fertility promoting proteins (i.e., the major gap junction protein
connexin 43 (Cx43), Mets1, Add1Scarb1 and MARCKSL1). T cell-derived TNF-alpha sig-
naling was required for chlamydial-induced infertility and caspase inhibitors prevented both
infertility and EMT. Thus, chlamydial-induced T cell-derived TNF-alpha activated caspases
that inactivated dicer, causing alteration in the expression of reproductive epithelial miRNAs
and induction of EMT. EMT causes epithelial malfunction, fibrosis, infertility, and the
enhancement of tumorigenesis of HPV oncogene-transformed epithelial cells. These find-
ings provide a novel understanding of the molecular pathogenesis of chlamydia-associated
diseases, which may guide a rational prevention strategy.
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Introduction
Chlamydia trachomatis genital infection is the most common bacterial STD worldwide. The
complications include pelvic inflammatory disease (PID), ectopic pregnancy and tubal factor
infertility (TFI). Also, chlamydia is a risk factor for human papilloma virus (HPV)-associated
cervical epithelial dysplasia (intraepithelial neoplasia) and cervical carcinoma [1]. Apart from
the clinical evidence of tubal obstruction attributed to inflammation-driven fibrosis [2], the
molecular pathogenesis of genital chlamydial complications or its co-factor role in HPV-
related cervical carcinoma remains unclear. However, recent reports revealed that chlamydial
genital infection caused significant alterations in host regulatory micro-RNA (miRNA) expres-
sion profiles in the reproductive system [3–5]. MiRNAs are an evolutionarily conserved, short
(~22 nucleotides) non-coding RNAs that posttranscriptionally regulate gene expression by
binding to complementary 3’UTR of mRNAs, resulting in mRNA degradation, translational
repression or occasionally enhancement. Physiologically, miRNAs regulate gene expression
during cellular differentiation, reproduction, development, maintenance of cellular integrity,
functions and normal metabolism, as well as in pathologic fibrosis and oncogenesis, accounting
for approximately 30% of mammalian gene expression [6]. Furthermore, Chlamydia-induced
disruption of reproductive tissue miRNAs expression was associated with the activation of spe-
cific caspases that target Dicer [3], a ribonuclease III critical in the biogenesis of miRNAs and
siRNAs [6]. The miRNAs altered during chlamydial infection included those that regulate epi-
thelial functional integrity [7]. This suggested that chlamydia may induce epithelial-mesen-
chyme transition (EMT) [7–9] that could affect fertility-related reproductive epithelial
functions and may also promote epithelial cell transformation and/or tumor progression.
EMT is an important miRNA-regulated biological process that converts normal polarized,
cobble-stone-like epithelial cells into fibroblastic (elongated) mesenchyme cells and conse-
quently alters epithelial integrity and functions. Mesenchymal cells exhibit enhanced motility
and migratory capacity, invasive capability, higher resistance to senescence and apoptosis, and
increased production of extracellular matrix (ECM) components [7,8]. EMT represents an
important phase in development, differentiation, inflammation, fibrogenesis and tumorigene-
sis [7,10]. Specifically, EMT is involved in cellular differentiation for specialized tissue forma-
tion and organogenesis during embryogenesis and development; production of myofibroblasts
from epithelial cells during fibrosis, tissue repair or wound healing after injury; secretion of
pro-inflammatory molecules by epithelial cells during inflammation; and initiating the invasive
and metastatic behavior of epithelial cancers [7]. Thus, EMT plays a major role in organ and
tissue fibrotic diseases, such as pulmonary, renal, and hepatic fibrosis [9]; however, its role in
the tubal fibrosis associated with genital chlamydial disease [2] has not been investigated. EMT
converts normal epithelial parenchymal tissue architecture into non-functional scar tissue dur-
ing fibrosis [11] and alter the normal differentiated functions of epithelial cells (i.e., secretory,
barrier and transport) [12–14]. Mechanistically, EMT inducers, including growth factors, hor-
mones (e.g., estrogen) and proinflammatory cytokines (TNF-alpha and TGF-beta) and their
receptors, activate intracellular signaling pathways (e.g., the Smad, PI3K/ERK and the Wnt/
beta-catenin pathways) that disrupt the fine miRNA regulatory processes maintaining the bal-
ance of E-cadherin on epithelial cells through interactions between miRNAs and key transcrip-
tion factors (TFs) [7–9]. Three families of TFs {SNAIL1/2 (i.e., SNAIL1 and SLUG), TWIST,
and zinc-finger E-box-binding, ZEB1} are the principal mediators of EMT; these TFs target the
repression of epithelial cadherin and other normal epithelial cell markers such as beta-catenin
and connexin proteins that are components of adherens, tight and gap junctions, causing loss
of adherens junctions and cell-cell adhesion. Loss of E-cadherin is the hallmark of EMT. Con-
comitantly, the EMT mediators activate key mesenchymal genes encoding mesenchymal cell
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markers, including N- and/or T-cadherin (cell-cell adhesion), vimentin (an intermediate fila-
ment protein that regulates cell motility), fibronectin 1 (cell growth and migration) and matrix
metalloproteinases. Changes in cellular gene expression pattern of the RHO GTPases drive
molecular changes leading to reorganization of cytoskeletal architecture, loss of epithelial tight
junctions and apical-basolateral polarity, acquisition of a front-rear polarity, changes in cell
shape with increased protrusions, and greater cellular motility for an invasive capability [7,9].
The key miRNA signature profile of EMT is the down-regulation of members of the miR-200
family, especially miR-429, which normally exerts suppressive function on negative regulators
of E-cadherin (e.g., ZEB1, TWIST and SNAIL1/2). In addition, there is the down-regulation of
tumor suppressors, such as p53, and upregulation of a number of tumor promoters that
involved in tumorigenesis and metastasis. The altered expression and dysregulation of key
miRNAs underlying these changes are caused by the action of EMT mediators such as ZEB1
[15].
EMT-inducing proinflammatory cytokines are also key mediators of endometritis, salpingi-
tis, tubal fibrosis and other inflammatory sequelae of genital chlamydial infection [16],
although the role of miRNA-driven EMT in the pathologic processes that culminates in repro-
ductive fertility-related complications was unknown. Besides, the contribution of infection-
induced EMT to fibrosis or invasive and metastatic carcinoma has not been studied. However,
chlamydia induces fibrosis [2] and is a strong co-factor for HPV-related cervical carcinoma [1]
although the molecular basis has been an enigma. Since chlamydial genital infection could
cause significant alterations in reproductive system miRNA expression profiles [3–5], we tested
the hypothesis that the molecular basis of chlamydia-induced infertility and chlamydia as a co-
factor in HPV-induced cervical epithelial carcinoma is the induction of EMT through miRNA
dysregulation. The result indicated that EMT is a caspase-driven pathological process induced
during chlamydial infection. EMT induction by chlamydia and the consequent alteration of
epithelial functional integrity may provide a molecular basis for reproductive infertility or the
co-factor role in HPV-induced cervical epithelial neoplasia and invasive carcinoma.
Results
Chlamydial genital infection caused a sustained alteration of key
miRNAs that control the functional integrity of epithelial cells
We recently showed that chlamydial genital infection leading to infertility or other pathologies
was associated with the cleavage inactivation of the key miRNA-synthesis enzyme Dicer [3].
Also, we and others have demonstrated the altered expression of several miRNAs in the repro-
ductive tissues of chlamydia-infected animals [3–5]. We investigated how the altered miRNAs
drove the pathogenesis of Chlamydia-induced reproductive diseases or provide a mechanism
for the co-factor role of Chlamydia in HPV-related reproductive epithelial carcinoma. It was
hypothesized that chlamydial genital infection will induce the altered expression of miRNAs
that control the functional integrity and homeostasis of the reproductive epithelium. We per-
formed a detailed quantitative comparative analysis of miRNAs from the oviducts of infected
(infertile) and non-infected (fertile) animals; we followed the miRNA dysregulation over a
period of time during which the pathophysiological processes associated with chlamydial infec-
tion do manifest; and we employed in silico functional analysis to determine if there were any
established relationships between the dysregulated miRNAs and the known complications of
chlamydia infection, including fibrosis, loss of epithelial functional integrity relating to repro-
duction, and promotion of epithelial neoplasia. Results presented in Table 1 are a list of Chla-
mydia-induced differentially expressed miRNAs with at least 2-fold down- or up-regulation
from oviducts harvested between 1 and 12 wk (80 days) post-infection, relative to non-infected
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Table 1. Chlamydia-Induced Sustained Differentially ExpressedmiRNAs (http://www.microrna.org/microrna/home.do; http://targetscan.org/).
# Differentially-4Expressed
miRNA
Fold-Change: Down (-)-/Up (+)
Regulation
Biological Function Relating to Epithelial Functional Integrity
and Tumorigenesis
Refs
1 miR-10b ~ 2-fold (-) Tumor control [105]
2 miR-15a ~ 5-fold (-) EMT control [17,18]
3 miR-16 ~ 3-fold (-) EMT control [17,18]
4 miR-17-3p ~ 2-fold (-) EMT/tumor control [83]
5 miR-21 ~ 4-fold (-) Cell growth
6 miR-24 ~ 3-fold (-)
7 miR-25 ~ 2-fold (-)
8 miR-27a ~ 4-fold (-)
9 miR-29a ~ 6-fold (-) Fibrosis and tumor suppressor [19,22]
10 miR-29b ~ 6-fold (-) Fibrosis and tumor suppressor [19,22]
11 miR-30a-3p ~ 2-fold (-) Tumor suppressor, apoptosis, replication
12 miR-30a-5p ~ 2-fold (-) Tumor suppressor, apoptosis, replication
13 miR-32 ~ 2-fold (-)
14 miR-100 ~ 2-fold (-)
15 miR-101-1 ~ 2-fold (-)
16 miR-103 ~ 2-fold (-)
17 miR-131 ~ 2-fold (-)
18 miR-136 ~ 2-fold (-)
19 miR-142-3p ~ 2-fold (-)
20 miR-143 ~ 3-fold (-)
21 miR-185 ~ 2-fold (-)
22 miR-190 ~ 2-fold (-)
23 miR-191 ~ 2-fold (-)
24 miR-198 ~ 3-fold (-)
25 miR-200a ~ 2-fold (-) EMT/tumor control [15,24,25]
26 miR-200b ~ 2-fold (-) EMT/tumor control
27 miR-200c ~ 2-fold (-) EMT/tumor control
28 miR-203 ~ 2-fold (-) EMT/tumor control [10]
29 miR-204 ~ 2-fold (-) EMT/tumor control [10]
30 miR-210 ~ 2-fold (-)
31 miR-214 ~ 2-fold (-)
32 miR-221 ~ 3-fold (-)
33 miR-296 ~ 2-fold (-)
34 miR-340 ~ 2-fold (-)
35 miR-372 ~ 2-fold (-)
36 miR-376a# ~ 2-fold (-)
37 miR-376b ~ 3-fold (-)
38 miR-379 ~ 2-fold (-)
39 miR-382 ~ 5-fold (-) Epithelial integrity [15]
40 miR-384 ~ 2-fold (-)
41 miR-409-5p ~ 3-fold (-) Epithelial integrity [15]
42 miR-411 ~ 2-fold (-)
43 miR-412 ~ 4-fold (-)
44 miR-422a ~ 5-fold (-)
45 miR-429 ~ 8-fold (-) EMT/tumor control [15,24,25]
46 miR-432 ~ 3-fold (-)
(Continued)
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fertile animals. Both gene expression pathway analysis, involving loss-of-function assays, and
in silico database search for miRNA targets in the relevant molecular pathways they regulate
(http://www.microrna.org/microrna/home.do; http://targetscan.org/), have established the
functional significance of several of these miRNAs.
From the functional analysis of miRNAs in Table 1, we have presented in Figs 1 and 2 (Fig
1: Down—regulated; Fig 2: Up-regulated) the detailed expression profiles of selected differen-
tially expressed miRNAs whose altered expressions were sustained over the indicated duration
of time after infection, and are known to regulate epithelial functional integrity relating to
reproduction, fibrosis or tumorigenesis. Among the down-regulated miRNAs, both miR-15a
and miR-16 control genes involved in epithelial cell viability, integrity and function, as well as
cell cycle progression and angiogenesis. Also, both miRNAs act as tumor suppressors, inhibit-
ing the expression of proteins involved in epithelial-mesenchyme transition (EMT) and tumor-
igenesis, especially the transcription factor Sox5 and Bcl2 [17,18]. The miR-29 family is
required to preserve epithelial tissues from fibrosis via targeting for suppression components of
extracellular matrix (ECM), especially collagen-I and -IV [8,19,20]; The suppression of the
miR-29a and miR-29b is associated with the induction EMT, and it is a major trigger for car-
diac and peritoneal fibrosis [20,21]; and so the suppression of members of miR-29 family dur-
ing genital chlamydial infection is an indication of onset of fibrosis in the oviducts, which is a
common pathologic consequence of genital chlamydial infection [2]. In addition, members of
miR-29 family control cell invasion by targeting for suppression molecules that are involved in
cell invasion and migration in the focal adhesion signaling pathway [22]; furthermore, miR-
29a targets the heat-shock protein-47 (HSP47), a member of the serpin superfamily of serine
proteinase inhibitors and a molecular chaperone involved in the maturation of collagen mole-
cules; HSP47 is upregulated in fibrosis and several cancers especially cervical intraepithelial
neoplasia where miR-29a is often down-regulated [23]. The miR-29s thus act as fibrosis and
tumor suppressors, and their down-regulation, as in the reproductive system during genital
chlamydial infection, leads to increased fibrosis and tumorigenesis. In addition, miR-203 and
miR-204 which regulate EMT were down-regulated by chlamydia to enhance EMT. The down-
regulated miRNA-382 and -409-5p are involved in controlling epithelial integrity and func-




Fold-Change: Down (-)-/Up (+)
Regulation
Biological Function Relating to Epithelial Functional Integrity
and Tumorigenesis
Refs
47 miR-9 ~ 6-fold (+) EMT inducer. Oncogenic [8,26,27]
48 miR-19a ~ 2-fold (+) EMT/oncogenic
49 miR-22 ~ 3-fold (+) Oncogenic. EMT inducer [28,29]
50 miR-122a ~ 2-fold (+)
51 miR-124a ~ 3-fold (+)
52 miR-199b ~ 3-fold (+)
53 miR-224 ~ 2-fold (+)
54 miR-324-5p ~ 3-fold (+)
55 miR-331 ~ 4-fold (+)
56 miR-342 ~ 2-fold (+)
57 miR-449 ~ 4-fold (+)
58 miR-449b ~ 4-fold (+)
59 miR-451 ~ 2-fold (+) Promotes cell migration & tumorigenesis [81]
60 miR-452 ~ 4-fold (+)
doi:10.1371/journal.pone.0145198.t001
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of miR-200 family (miR-200a, -200b, -200c and -429) that maintain epithelial integrity pheno-
type by preventing EMT through downregulation of EMT-promoting transcription factors,
especially the zinc finger E-box binding homeobox proteins ZEB1, ZEB2 and SIP1 proteins,
[15,24]. In particular, miRNA-429 targets ZEB1, a transcriptional repressors of E-cadherin and
other epithelial markers, and contraction-associated genes [15,24,25]. Thus, suppression of
miR-429 releases its suppressive effect on ZEB1 and other pro-EMT transcription factors,
thereby activating EMT that affects epithelial integrity, and promoting epithelial tumorigenesis.
So miR-429 suppression is a major route for EMT induction and epithelial tumor promotion,
which may be prominent in the genital epithelium during genital chlamydial infection.
Among the upregulated miRNAs during infection (Fig 2), miR-9 induces EMT by directly
targeting the mRNA encoding E-cadherin [8]; its ectopic expression induced EMT in human
mammary epithelial cells, and a sponge-trapping miR-9 consisting of multiple copies of a spe-
cific sequence complementary to miR-9 caused a reduction of invasiveness of a breast cancer
cell line, certifying miR-9 as an EMT inducer and oncogenic miRNA [26,27]. The upregulated
miR-19a affects epithelial integrity by regulating angiogenesis, epithelial differentiation, cell
signaling through NF-kB, and cell proliferation. Also upregulated is the oncogenic miR-22
Fig 1. Chlamydial genital infection caused a sustained alteration of key miRNAs that control the functional integrity of epithelial cells (down-
regulatedmiRNAs). Analysis of the pattern of expressed miRNAs in the oviducts of infected infertile mice and non-infected mice employed a combination of
microarray and quantitative real time PCR as per Signosis’miRNA Array IV service (Signosis, Inc. Sunnyvale, CA), as described in the Materials and
Methods section. The labeled oligonucleotide probe mixture corresponded to 540 randomly selected miRNAs which have been reported to play a role in
inflammation, apoptosis and cancer by literature search [101]. Quantitative Real-Time PCR was used to validate the microarray data using miRNA-specific
oligo mix. Information about miRNA target mRNA genes was obtained from several Web-accessible miRNA database searching programs, including http://
www.microrna.org, http://www.miRBase.org, http://www.targetscan.org and published reports [102]. Results presented in Table 1 (are shown as Fig 1
Down-regulated) were derived from oviducts harvested from 1 wk through at 80 days (11.4 wk) post-infection. Experiments were repeated 4 times with at
least 6 oviducts in each group. Statistically significant changes had P value from 0.05.
doi:10.1371/journal.pone.0145198.g001
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that triggers EMT, inhibits the ten-eleven-translocation gene 2 (TET2) tumor suppressors,
causing an enhanced hematopoietic stem cell self-renewal, transformation and metastasis
[28,29]. Finally, the upregulated miR-451 promotes cell migration and tumorigenesis. The
results indicated that chlamydia infection altered the expression of miRNAs that control epi-
thelial functional integrity and EMT, suggesting that chlamydia may induce EMT and the
pathophysiological processes, including fibrosis, luminal and glandular epithelial tissue dys-
function and tumor promotion.
Chlamydia infection of reproductive epithelial cells induces epithelial-
mesenchyme transition (EMT)
We investigated whether chlamydial infection of isolated reproductive epithelial cells can
induce EMT by altering epithelial characteristics and functions marked by suppression of E-
cadherin and other epithelial markers with concomitant upregulation of mesenchymal mark-
ers. Results presented Figs 3 and 4 indicate that chlamydial infection of primary reproductive
epithelial cells caused the downregulation of markers associated with normal epithelial integ-
rity (E-cadherin and Occludin) (panel 2A) and the upregulation of mesenchymal markers
(Snail1/2, Fibronectin, MMP9, T-Cadherin and ZEB1)(panel 2B) as an indication of EMT
induction. So, chlamydia induces EMT, a major pathophysiological process associated with tis-
sue fibrosis, loss of epithelial function and tumor invasion and metastasis [8,30]. Evidence for
chlamydial induction of EMT in vivo was demonstrate by immunohistochemical staining of
reproductive tract tissues from infected mice to identify mesenchymal markers. Thus, when
immunohistochemistry (IHC) assays were performed on sections of oviduct tissues from
infected and non-infected mice, it was found that immunostaining of T-cadherin, a marker of
Fig 2. Chlamydial genital infection caused a sustained alteration of key miRNAs that control the functional integrity of epithelial cells (up-
regulatedmiRNAs). Results were obtained as described in Fig 1 and selected miRNAs that were up-regulated have been presented.
doi:10.1371/journal.pone.0145198.g002
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mesenchymal phenotype was upregulated in the oviducts from infected mice mainly in the
lamina propria and interstitial connective tissues (Fig 5). The dramatic increase in T-cadherin
in infected oviducts was greater on day 7 post-infection compared to day 28 post-infection ovi-
ducts. Although a clear difference is yet to be observed in the expression of E-cadherin between
infected and non-infected oviducts, the results indicated that there was upregulation of at least
Fig 3. Chlamydia infection of reproductive epithelial cells induces epithelial-mesenchyme transition (EMT) (Loss of epithelial markers).
Monolayers of murine oviduct epithelial cells were infected withC. trachomatis L and after 72h immunofluorescence staining of the cells for epithelial markers
was performed on infected and non-infected monolayers by standard procedures. Fluoresceinated antibodies against the following markers were used: E—
cadherin and occlusin. Antibodies stained both intracellular and surface antigens. Images were acquired at 20X objective on a Nikon fluorescent microscope
with the same microscope settings and exposure time. The representative slides are from several repeated experiments showing identical results.
doi:10.1371/journal.pone.0145198.g003
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a reliable mesenchymal marker in the genital epithelium after genital chlamydial infection,
indicating that Chlamydia also induced EMT in vivo.
Chlamydia infection caused the altered expression of proteins that
regulate epithelial functional integrity, EMT and tumorigenesis in the
reproductive system
We hypothesized that chlamydia will alter the expression of proteins that regulate epithelial
integrity, physiologic functions and pathologic EMT in the reproductive system, and several of
these proteins will be targets of miRNAs that control epithelial integrity through EMT. Using a
quantitative iTRAQ and LC-MS analysis, we identified proteins that were differentially
expressed (either up- or down-regulated) in the oviducts from chlamydial infected mice, as
compared to uninfected mice. Fig 6 presents a list of upregulated proteins. Notable among
these proteins are: PRAP1 (proline-rich acidic protein 1), a hormonally regulated, luminal epi-
thelium-specific protein that is a marker for successful embryo implantation because it is
expressed when the embryo has been situated at the implantation site [31]. The up-regulation
of PRAP1 in the oviduct following genital chlamydial infection (3- to 11-fold between 2 and 4
wk post-infection) is prognostic for premature implantation in the oviduct that causes ectopic
Fig 4. Chlamydia infection of reproductive epithelial cells induces epithelial-mesenchyme transition (EMT) (mesenchymal markers).Monolayers of
murine oviduct epithelial cells were infected withC. trachomatis L and after 72h immunofluorescence staining of the cells for EMTmarkers was performed on
infected and non-infected monolayers by standard procedures. Fluoresceinated antibodies against the following markers were used: T-cadherin, Snail1/2,
fibronection, Zeb1 and MMP9. Antibodies stained both intracellular and surface antigens. Images were acquired at 20X objective on a Nikon fluorescent
microscope with the samemicroscope settings and exposure time. The representative slides are from several repeated experiments showing identical
results.
doi:10.1371/journal.pone.0145198.g004
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pregnancy. Chlamydia also dramatically upregulated the potent EMT-inducing and fibrogenic
protein, thrombospondin 1(Thbs1 or Tsp1) by 3- to 31-fold in 2–4 wk p.i. The Bcl-2-associated
athanogene 6 BAG6 (also called BAT3), encoded within the class III region of the human
MHC is involved in the ubiquitin-dependent elimination of defective, mis-localized, misfolded
and aggregation-prone proteins that prevents aggregated misfolded protein diseases, as well as
in cell survival, membrane protein biogenesis and apoptosis regulation [32]. The upregulated
high mobility group box 3 (HMGB3) protein is a member of a family of proteins containing
one or more high mobility group DNA-binding motifs and plays an important role in DNA
replication, recombination, and repair; HMGB3 is under the control of tumor suppressive
miRNAs such as miR-205 and is overexpressed in a variety of human cancers where those miR-
NAs are suppressed, and proposed to regulate cancer stemness [33,34]. Supervillin (Svil)
[35,36] is a peripheral membrane protein that binds F-actin and myosin II, reorganizes the
Fig 5. In vivo evidence of EMT after genital chlamydial infection. Immunohistochemistry (IHC) assays on sections of oviduct tissues from infected and
non-infected mice were performed by using a polymer-based colorimetric indirect immunoalkaline phosphatase method with a polyclonal rabbit anti-T-
cadherin antibody, as previously described [100]. Images were acquired at 20X objective on a Nikon fluorescent microscope. The representative slides are
from several repeated experiments showing identical results.
doi:10.1371/journal.pone.0145198.g005
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Fig 6. Chlamydia infection caused the altered expression of proteins that regulate epithelial functional integrity and pathologic EMT in the
reproductive system (up-regulation). The quantitative differential proteomics with isobaric tags for relative quantitation (iTRAQ) labeling and LC-MS
analysis was used to identify proteins that were differentially expressed in the oviducts from chlamydial infected mice, as previously described [103,104].
Briefly, trypsinized proteins extracts were labeled using the 114, 115, 116 and 117 iTRAQ tags and analyzed by MS, as described in the materials and
Methods section. Protein/peptide identification and quantification were performed with the Protein Pilot Software version 4.5 and MASCOT, including the
search of the database for murine or human proteins (http://www.uniprot.org). Fold Change represented protein expression in infected oviducts divided by
protein expression in uninfected oviducts. The down-regulated molecules were expressed in percentage to avoid negative values. Only protein identified by
at least 2 peptides and with a P-value < 0.05 were used for quantitation. The biological and functional properties of the proteins and their physiological and
disease pathways were established through http://www.elsevier.com/online-tools/pathway-studio (Pathway studio 10; www.elsevier.com/online-tools/
pathway-studio) and other specialized biomedical databases that include PubMed and Medline searches.Results showmolecules upregulated at D14 and
D28 p.i.
doi:10.1371/journal.pone.0145198.g006
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actin cytoskeleton and potentiates invadopodial function, thereby facilitating cell motility; Svil
suppresses the tumor suppressor p53, prevents apoptotic cell death by enhancing cell survival,
and it therefore plays a role in tumorigenesis. The suppressor of mec-8 and unc-52 homolog
protein (Smu1) is a WD40-repeat protein encoded by an evolutionarily conserved gene found
in most eukaryotic organisms and it is important for regulating DNA replication and cell
growth [37]. The Sm-like protein, Lsm1 is an oncogene [38,39] that forms part of a cytoplasmic
protein complex, Lsm1-7-Pat1, which is involved in mRNA degradation, turnover and control
of gene expression through the 5'-to-3' mRNA decay pathway, linking deadenylation to decap-
ping. It regulates histones mRNAs to ensure genomic stability. Lsm1 is over-expressed in mul-
tiple tumor types, including over 80% of pancreatic tumors, and increased levels of Lsm1
protein have been shown to induce carcinogenic effects [39]. The fragile-X-mental retardation-
related protein 1 (FXR1) is an RNA-binding protein [40] that regulates the translation of key
cytoskeletal components in myoblasts and therefore critical for muscle development; and its
co-regulation with miR-29 suggested it plays a role in fibrosis [19]. PSMD14 and PSMB5 are
components of the 19S and 20S proteasome, respectively that are involved in the deubiquitina-
tion during proteasomal degradation and cell cycle events that ensure cell growth, survival, and
stemness that prevents senescence [41]. COP9 signalosome subunit 2 (Cops2) is one of the 8
subunits of COP9 or CSN (CSN1-CSN8) [42,43] The COP9 signalosome (CSN) is an evolu-
tionarily conserved protein complex with homologies to the 19S lid subcomplex of the 26S pro-
teasome. COP9 play a role in regulating the degradation of polyubiquitinated proteins
including tumor suppressors and cell cycle proteins involved in cell proliferation, senescence,
EMT and tumorigenesis [44]. Actr1a is a member of the actin-related proteins (ARP) with
cytoskeletal function relating to cell migration and membrane transport; it has altered expres-
sion in certain cancers [45]. Txn2 is thioredoxin 2 (Trx2), a key mitochondrial protein that reg-
ulates cellular redox and survival by suppression of mitochondrial reactive oxygen species
generation and inhibition of apoptosis stress kinase-1 (ASK1)-dependent apoptotic signaling
[46]. Dpm3 is the third subunit of the dolichol-phosphate-mannose (DPM) synthase complex
located on the endoplasmic reticulum and required for protein gycosylation modification [47].
The upregulation of Dpm3 may indicate heightened ER activity and possibly ER stress. The
fatty acid-binding protein-3 (FABP3) is important for fatty acid transport and play a role in
cell survival [48]. Thus, these results validated the hypothesis that genital chlamydial infection
will up-regulate the expression of proteins that promote pathogenic EMT, fibrosis, epithelial
dysfunction, and tumor promotion in the reproductive system, and several of the proteins are
targets of miRNAs that control epithelial integrity EMT.
Fig 7 presents a list of down-regulated proteins in the oviducts from chlamydial-infected
mice, as compared to expression levels in oviducts from sham/non-infected animals. Notable
among the down-regulated proteins that are at least 50% lower than normal expression in the
absence of infection are: The gap junction a-1 protein (Gja1), also called the major gap junction
protein Connexin 43 (Cx43), is a contractility-associated protein that is markedly enhanced in
response to estrogen in the reproductive tract epithelial stromal cells and the embryo during
the early phases of pregnancy. It plays a vital role in oviduct contraction for embryonic trans-
port, implantation and parturition [49–51]. The down-regulation of Cx43 in the oviduct dur-
ing chlamydial infection indicates a decreased tubal contractility that may cause ectopic
pregnancy. Gap junction-targeting has also become a pathogenic mechanism of certain infec-
tious agents, including reproductive system diseases such as endometritis and inflammatory
CNS diseases [51,52]. A STAT3-signaling mediated regulation of levels of IL-6 is required for
successful pregnancy [53] and the IL-6/STAT3 signaling pathway has anti-senescence and
growth-promoting functions in human tumors [54]. STAT3 signaling involving the leukemia
inhibitory factor (LIF) is critical for embryo implantation and reproductive fertility, and LIF
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deficiency is associated with unexplained recurrent abortion and infertility in women and inac-
tivation of STAT3 causes pregnancy failure [13,55]. The down-regulation of STAT3 in chla-
mydia-infected infertile mice therefore predicts pregnancy failure and infertility observed in
these mice. UCHL3 is ubiquitin carboxyl-terminal esterase L3 or ubiquitin thioesterase or ubi-
quitin hydrolase, one of the deubiquitinating enzymes (DUBs) that control proteolysis by
reversing ubiquitination in the regulation of the ubiquitin-proteasome protein degradation sys-
tem (UPPDS); the aberrant reduced or blocked expression of UCHL3 compromised epithelial
functional integrity by reducing epithelial sodium channel [56] and affects fertilization and
pre-implantation embryonic development in vivo [57]. Add1 is a component of adducin
(ADD), a heterodimeric actin-binding cytoskeleton protein consisting of an α-subunit with
either a beta- or a gamma-subunit where the alpha-subunit (Add1) is known to increase renal
sodium reabsorption and therefore considered to be involved in the pathophysiology of essen-
tial hypertension [58] possibly through regulation of epithelial sodium channel. Its downregu-
lation in chlamydial infected infertile animals would suggest an alteration in epithelial
functional integrity. Disabled-2 (Dab2) is an epithelial polarity-determining protein crucial for
epithelial cell apico-basolateral orientation and epithelial organization during development,
and as an endocytic adaptor protein with a major role in clathrin-mediated endocytosis and
trafficking and recycling of membrane proteins [59,60]. Dab2 is also considered a tumor
Fig 7. Chlamydia infection caused the altered expression of proteins that regulate epithelial functional integrity and pathologic EMT in the
reproductive system (Down-regulation).Results were obtained as described in Fig 6 and selected molecules that were down-regulated have been
presented.
doi:10.1371/journal.pone.0145198.g007
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suppressor and lost in several malignant cancers [61]. The loss of Dab2 during chlamydial
infection will favor EMT, loss of epithelial polarity and function, and tumor promotion. The
C-terminal-binding protein 1 (Ctbp1) is a transcriptional corepressor that may play a role in
controlling EMT and fibrosis by suppressing MMP9 [62], apoptosis and cell proliferation [63].
Mets1 is mesenchyme-to-epithelium transition (reverse EMT) protein with SH3 domains 1
(also known as CD2-associated protein (CD2ap) [64,65], acting as an adapter protein between
membrane proteins and the actin cytoskeleton; it plays a role in receptor clustering and cyto-
skeletal and apico-basolateral polarity; deficiency of CD2ap causes defects in epithelial foot
processes, accompanied by mesangial cell hyperplasia and ECM deposition. Down-regulation
of Mets1 during chlamydial infection would favor EMT, fibrosis and compromised epithelial
functional integrity. CD2ap is a target of miR-199 regulation. The mitochondrial carrier homo-
log-2 (Mtch2) protein regulates membrane permeability and apoptosis and its suppression by
miR-135b promotes certain carcinomas [66,67]. Myristoylated alanine-rich C kinase substrate-
like 1 (MARCKSL1) is a tumor suppressor that regulates actin cytoskeleton, cell movement,
EMT, fibrosis and the invasiveness and metastasis of tumors by suppressing lysyl oxidase-like 2
(LOXL2) and the FAK/Akt/mTOR signaling pathways [68] The down-regulation of
MARCKSL1 by chlamydia promote EMT, fibrosis and tumorigenesis. Deoxythymidylate
kinase (thymidylate kinase, Dtymk) is important for cellular DNA synthesis and appears to act
with the tumor suppressor LKB1/STK11 to coordinates cell growth, polarity, motility, and
metabolism [69]. SART1 is a spliceosome factor involved in RNA splicing and pre-mRNA pro-
cessing, and a regulator of IFN's antiviral effects [70]. Sdf4 is a member of the stromal cell
derived factor (SDFs) family and functionally classified as a chemokine; SDF-2, SDF-4 and
SDF-5 are expressed in mammary tumor tissues and cells and a reduced level of SDF-2,
SDF2-L1 and SDF-4 are associated with a poor clinical outcome [71]. Sodium/hydrogen
exchanger 1 (Slc9a1 or NHE-1) is regulator of membrane permeability, sodium ion transport,
apoptosis, cell differentiation and growth; it is suppressed during ER stress that causes epithe-
lial injury [72]. The down-regulation of NHE-1 during chlamydial infection would indicate the
induction of ER stress. Scarb1 encodes the scavenger receptor class B type 1 (SR-B1) that is
important for female hormonal synthesis, steroidogenesis and fertility; its knock down led to
reproductive infertility [73,74]. Thus, its down-regulation during genital chlamydial infection
would suggest that the mice will be infertile. The death domain-containing membrane protein,
neurotrophin receptor associated death domain (NRADD), also known as Neurotrophin
receptor-alike death domain protein (Nrh2) promotes apoptosis through [75]. Its down-regu-
lation is anti-apoptotic, which would promote cell survival and tumorigenesis. These results
confirm the converse hypothesis that genital chlamydial infection will down-regulate proteins
that promote reproductive fertility, normal epithelial function or that control pathologic EMT.
The role of T cell-derived TNF-alpha and caspase activation in
chlamydial-induced infertility and EMT
The requirement for T cells, the T cell-derived cytokine TNF-alpha and caspase-3 for chlamyd-
ial-induced infertility and tubal pathologies [3,76–78] suggested that the pathogenesis of chla-
mydial reproductive complications involved TNF-alpha signaling and caspase activation.
Thus, the corroborative results presented in Fig 8 indicates that, although TNF-alpha -/- mice
are resistant to chlamydia-induced infertility, the adoptive transfer of T cells from wild-type
(TNF-alpha+/+) mice into knockout (KO) mice restored infertility in infected mice. Since TNF-
alpha is a potent EMT inducer [7], recent results showing that caspase activation by chlamydia
caused the cleavage inactivation of dicer, a key enzyme in miRNA biosynthesis [3], suggested
that alteration in dicer activity led to changes in expression of miRNAs that drive EMT and the
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pathologic consequences. In fact, female animals with targeted knockout of dicer from the
reproductive tissues exhibited miRNA dysregulation, infertility and oviduct pathologies similar
to tubal factor infertility in humans [79]. And the local application of caspase inhibitors pre-
vented chlamydia-induced infertility [3]. Therefore, we reasoned that, if caspase activation,
Dicer inactivation and miRNA dysregulation are the drivers of EMT that causes Chlamydia-
induced reproductive pathologies, EMT should be sensitive to caspase inhibition as well. Thus,
as a mechanistic investigation of the role of caspase activation in EMT induction, and the possi-
bility of pharmacological intervention, we tested the hypothesis that caspase inhibition would
prevent chlamydial-induced EMT. As shown in Fig 9, treatment of infected epithelial cells with
the pan-caspase inhibitor Z-VAD-fmk prevented EMT, marked by retention of normal epithe-
lial E-cadherin and suppression of mesenchymal MMP9, SNAIL1/2, T-cadherin, ZEB1 and
estrogen receptor-beta markers and regulators. Perhaps this is the first report of EMT inhibi-
tion by an anti-caspase agent, which opens up a new translational approach to therapeutic tar-
geting of EMT-driven diseases such as fibrosis and tumor promotion, requiring safe, non-toxic
and human compatible caspase inhibitors.
Discussion
We investigated the molecular pathogenesis of the complications of genital chlamydial infec-
tion and as a co-factor in HPV-associated cervical epithelial carcinoma. We tested the hypothe-
sis that chlamydia induces pathologic EMT that alters fertility-related epithelial functions,
promotes fibrosis and tumorigenesis. The results so far have revealed that chlamydia induces
EMT, involving the activation of T cells, TNF-alpha signaling, the caspases, dicer inactivation,
Fig 8. Role of T cell-derived TNF-alpha in chlamydial-induced infertility.Groups of female mice (TNF-
alpha-/-, controls TNF-alpha+/+, and TNF-alpha-/- that received 107 purified T cells from TNF-alpha++ mice)
were infected intravaginally with C. trachomatis L2 (WT-L2), as described in the Materials and Methods
section. Infected and noninfected control mice were mated and scored for pregnancy and no. of pups. The
plotted data are the means (SEM) for groups from 2 independent experiments with 6 mice per experimental
group.
doi:10.1371/journal.pone.0145198.g008
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the disruption of crucial miRNAs and proteins that regulate fertility and epithelial functional
integrity, and promotes fibrosis and tumorigenesis in the reproductive system [9]. Among the
down-regulated miRNAs is the miR-29 family that protects epithelial tissues from fibrosis
[8,19,20]. EMT promotes fibrosis by converting resident epithelial cells into apoptosis-resistant
myofibroblasts that deposit ECM proteins; and unlike in wound healing, the cells persist in
ECM causing a hypertrophic scar or keloid on tissues or fibrosis in organs, compromising
organ function, and sometimes causing organ failure [9]. The suppression of the miR-29a and
miR-29b induces EMT, and culminated in cardiac, kidney, pulmonary and peritoneal fibrosis
but could be ameliorated with miR-29 gene therapy [20,21]. Thus, the suppression of members
of miR-29 family following genital chlamydial infection is an indication of onset of EMT and
fibrosis in the reproductive system, which is a common pathologic consequence [2]. Perhaps
this is the first reported finding of the suppression of miR-29b as a likely cause of tubal fibrosis
during genital chlamydial infection, suggesting that chlamydia-induced fibrosis may benefit
from a miR-29-based gene therapy in future. In addition, members of miR-29 family control
cell invasion by suppressing molecules involved in cell invasion and migration in the focal
adhesion signaling pathway, including laminin gamma1 (LAMC1), laminin gamma1
(LAMC2) and alpha6 integrin (ITGA6) [22]; and heat-shock protein-47 (HSP47), a target of
Fig 9. Caspase inhibition prevented chlamydial-induced EMT.Monolayers of murine oviduct epithelial cells were infected withC. trachomatis L and after
72h immunofluorescence staining of the cells for epithelial and EMTmarkers was performed on infected and non-infected monolayers by standard
procedures. Z-VAD-FMK and the control Z-FA-FMK were used in culture at 50 micromole. Quantification of fluorescence was performed by scanning
fluorescent-stained cells at 20X objective on a Nikon fluorescent microscope using the NIS-Elements Imaging Software version 3.20 (Nikon Instruments Inc,
Melville, NY USA). Images were acquired for experimental and control cultures with the samemicroscope settings, exposure time and background. The
mean fluorescence intensity and standard deviations of 6 out of 10 scanned fields per slide were calculated automatically by the software. Plotted data were
derived from 5 independent experiments.
doi:10.1371/journal.pone.0145198.g009
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miR-29a, is involved in the maturation of collagen molecules, and is upregulated in fibrosis
and several cancers especially cervical intraepithelial neoplasia where miR-29a is often down-
regulated [23]. Furthermore, miR-429 is an active inhibitor of the transcription factors that
mediate EMT, including direct suppression of ZEB1 to maintain E-cadherin expression. Silenc-
ing the miR-200 family, especially miR-429, induces EMT and tumor promotion in several
experimental and clinical practice systems [9]. In addition, miR-204 suppresses EMT by
directly repressing TGF3R2 and SNAI2 (SLUG) to prevent the down-regulation of claudin
junctional proteins and preserve cell membrane voltage and conductance that ensure epithelial
physiology and barrier functions; and miR-203 suppresses EMT by promoting mesenchyme-
to-epithelial transition (MET) [10]. On the other hand, among the up-regulated miRNAs,
miR-9 induces EMT by its direct action on CDH1, the E-cadherin gene; and as an oncogenic
miRNA, it is upregulated in several primary and in metastatic cancers [9]. MiR-22 promotes
stemness and metastatic phenotype of cancer stem cells through suppression of the miR-200
family by increasing the methylation of their genes [80,81]. The persisting dysregulation of
miRNAs after chlamydial infection implied that EMT and its pathophysiologic consequences
have long-term effects.
The demonstration that Chlamydia infection can directly induce EMT in vitro and in vivo,
marked by E-cadherin loss or a cadherin switching from E- to N- or T-cadherin is the proto-
typical marker of EMT [8]. E-cadherin is required to maintain epithelial functional integrity by
its role in cell-cell adhesive interaction through its cytoskeletal interactions with cytoplasmic
catenins that provide the epithelia cobble-stone-like tissue architecture, ensure epithelial bar-
rier, and aggregate forms as functional tissue glands. Also, E-cadherin is critical for post-fertili-
zation embryo-maternal interaction in the oviduct and uterus, for preimplantation embryonic
survival, decidualization and implantation, and female fertility [13]. In fact, women with endo-
metriosis show a remarkably down-regulated E-cadherin and beta-catenin expression in the
epithelial cells of their mid-secretory endometrium [13]. On the other hand, T-cadherin
expression promotes cell motility, invasiveness, migration and survival to enhance tumorigene-
sis [82]. Thus, chlamydia-induced EMT-associated alteration of cadherins in the luminal epi-
thelium of the oviduct can cause reproductive abnormalities. More so, Chlamydia induced
pro-EMT transcription factors and regulators, including the zinc finger E-box binding
homeobox protein, ZEB1 and Snail1/2, thrombospondin1 (Thbs1 or Tsp1). Tsp1 is upregu-
lated in several cancers especially those with invasive properties, such as endometrial cancer
where its upregulation inversely correlated with miR-17-5p [83]; and its down-regulation by
siRNA-mediated silencing or antibody neutralization reduced invasiveness and inhibited in
vivomotility of cancer cells [84,85]. Other proteins upregulated by chlamydia in the reproduc-
tive system that contribute to EMT, fibrosis, oncogenesis and tumor progression, invasiveness
and metastasis are BAG6 (also called BAT3) [32], the HMGB3 protein [33,34], Svil [35,36],
Smu1 [37], the oncogene Lsm1 [38,39], FXR1 [40], PSMD14 and PSMB5 [41], Cops2 or CSN2,
[42–44], Actr1a [45], Txn2 or Trx2 [46], Dpm3 [47], and FABP3 [48]. Several EMT inducers
such as cytokines, hypoxia, bile acids and nicotine also promote tumorigenesis by enhancing
invasive cell growth, local invasion and distant spread [9]. The role of chlamydia-inducible,
cytokines such as TNF-alpha and TGF-beta in EMT and fibrosis has been well established [86].
Thus, the ability of estrogen to induce EMT involving miRNA alterations [87], and our results
showing that chlamydia induced EMT and estrogen receptors, would suggest that chlamydia
may induce EMT via the estrogen receptor-signaling pathway. Consistent with the miRNA
profiles and up-regulation of pro-EMT proteins, our results further showed that the chlamydial
down-regulated proteins are those that maintain epithelial integrity, support reproductive fer-
tility, control fibrosis and act as tumor suppressors. Among these, the major gap junction a-1
protein (Gja1; or Connexin 43, Cx43), is required for oviduct contraction for embryonic
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transport to the uterus, implantation and parturition [49–51]. The down-regulation of Cx43 in
the oviduct during chlamydial infection indicates a decreased in tubal contractility that may
cause ectopic pregnancy and poor embryonic development. Other relevant down-regulated
proteins are: STAT3, the leukemia inhibitory factor (LIF), ubiquitin carboxyl-terminal esterase
L3 (UCHL3), Add1 (a component of adducin, ADD), disabled-2 (Dab2), and an epithelial
polarity-determining protein crucial for epithelial cell apico-basolateral orientation and epithe-
lial organization, Ctbp1. Also down-regulated are: Mets1 (a mesenchyme-to-epithelium transi-
tion protein), CD2-associated protein (CD2ap), the mitochondrial carrier homolog-2 (Mtch2),
myristoylated alanine-rich C kinase substrate-like 1 (MARCKSL1) protein, lysyl oxidase-like 2
(LOXL2), deoxythymidylate kinase (thymidylate kinase, Dtymk), SART1, the stromal cell
derived factor-4 (SDF4), sodium/hydrogen exchanger 1 (Slc9a1 or NHE-1), Scarb1 (the scav-
enger receptor class B type 1; SR-B1), and neurotrophin receptor associated death domain
(NRADD or Nrh2). These molecules are required for either successful pregnancy, implanta-
tion, maintenance of epithelial integrity, or control of EMT and fibrosis, and tumor suppres-
sion [13,53–61,63–75,88–90].
The sensitivity of chlamydia-induced EMT and infertility to caspase inhibitors [3] con-
firmed that caspase inhibition of dicer represents a key upstream initiating event for miRNA-
mediated, chlamydia-induced EMT; this finding validates the proposed link between caspase
activation, miRNA disruption due to dicer inactivation, and EMT induction. Furthermore,
clinico-pathologic studies indicate that the acquisition of invasive and metastatic characteris-
tics by transformed cells involves the induction of EMT, the down-regulation of tumor sup-
pressors such as p53, and the maintenance and expansion of cancer stem cells, CSCs. EMT
inducers such as TNF-alpha signaling through both the canonical Smad and non-Smad (Akt
and ERK1/2), Wnt and focal adhesion pathways [9] activate oncogenic TFs and miRNAs
whose gene expression regulation cause the enhancement of cell migration and epithelial scat-
tering characteristic of EMT [8]; and this drives a subset of transformed primary epithelioid
cells into self-renewing tumor-initiating cells or CSCs, (CD44hiCD24low) that efficiently gener-
ate new tumors due to clonal expansion, motility and invasive state that enable them to initiate
local invasion and distal metastasis [7,9]. Thus, EMT-inducing agents are co-factors in the
development and progression of several cancers [9]. Our working hypothesis is that EMT-
inducing agents, including cytokines, estrogen [87,91] and chlamydia, are co-factors for HPV-
related invasive cervical carcinoma. Cervical cancer is the most common malignancy in females
worldwide and a leading cause of mortality among gynecological cancers. Oncogenic types of
HPV (e.g., 16 and 18) are important in the development of precursors of cervical cancer [92]
but the fact that only a fraction of HPV-infected females develop the cervical carcinoma has
prompted the search for co-factors in the progression to invasive cervical cancer [93]. Our
results are consistent with the hypothesis that chlamydial induction of EMT during co-infec-
tion with HPV provides the pathophysiological basis for the cofactor in HPV-induced cervical
carcinoma. An ongoing study is using the HPV 16 E6/7 transgenic mouse model that requires
estrogen as co-factor for accelerated development of invasive cervical carcinoma [94,95], to
determine whether chronic genital chlamydial infection can replace estrogen in disease patho-
genesis. Besides, while evidence of EMT has been observed in the induction or progression of
several tumors, our finding may represent the first evidence of a direct relationship between a
co-factor and EMT. Thus, these findings provide a novel understanding of the molecular path-
ogenesis of chlamydia-induced infertility and its co-factor role in cervical carcinoma, which
may guide to a rational strategy to prevent complications. Targeting EMT and especially the
components of the signaling pathways of inducers with small molecule inhibitors such as
antagomirs, siRNA- or anti-sense oligonucleotide, miRNA sponges, or antibodies and chemical
inhibitors, represents an important therapeutic strategy for the clinical management of fibrosis
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and cancers [9]. Conversely, synthetic miRNAs administration can be used as a replacement
therapy for EMT-/tumor-suppressor miRNAs that are commonly down-regulated in fibrosis
and cancers [96]. Our present study may add a therapeutic option of targeting the caspases to
control EMT and the pathophysiologic consequences.
Materials and Methods
Chlamydia trachomatis stock, animal infection and assessment of
infertility
Stocks of C. trachomatis serovar L2, were propagated in HeLa cells and the purified elementary
bodies (EBs) were titered as inclusion-forming units per milliliter (IFU/ml) by standard proce-
dure [76]. Female TNF-alpha knockout (B6.129-TNFtm1LjoN7)(TNF-alpha-/-) wild-type
C57BL/6) (TNF-alpha+/+) mice, 5–8 weeks old, were obtained from either Taconic Farms, Inc
(Hudson, NY) or Jackson Laboratory (Bar Harbor, MA) Mice were infected intravaginally with
1x105 IFU per mouse with C. trachomatis serovar L2 while under the long-acting anesthetic
sodium pentobarbital (30 microgram/body weight)(Sigma-Aldrich, St Louis, MO) approxi-
mately 5 days after intramuscular administration of 2.5 microgram/mouse Depo Provera
(medroxy-progesterone Acetate; Pfizer Inc, NY, NY). These conditions are a key factor to a
successful mouse model of chlamydial genital infection using the human chlamydial strains
[97]. Control mice were sham infected with PBS. The infection and infertility were assessed by
tissue culture isolation of chlamydiae from cervico-vaginal swabs and enumeration of chla-
mydial inclusions by immunofluorescence method [76] and mating of mice with proven fertile
males, as previously described [98]. In addition to fertility assessment, animals were visually
and microscopically inspected and scored for uni- and bilateral hydrosalpinx or cysts, and
presence of other abnormalities in the reproductive system [98,99]. All animal protocols were
approved by the CDC Institutional Animal Care and Use Committee (IACUC).
Immunohistochemistry
The murine oviduct epithelial cell line (C57epi.1) that supports the growth of chlamydiae was
kindly provided by Dr Raymond Johnson, Indiana Univ., Indianapolis, IN, USA. Immunofluo-
rescence staining of epithelial cells for EMT markers was performed on chlamydial-infected
(MOI = 1) and non-infected monolayers by standard procedures after 72h of infection.
Z-VAD-FMK and the control Z-FA-FMK were used in culture at 50 micromolar. Quantifica-
tion of fluorescence was performed by scanning fluorescent-stained cells at 20X objective on a
Nikon fluorescent microscope using the NIS-Elements Imaging Software version 3.20 (Nikon
Instruments Inc, Melville, NY USA). The mean fluorescence intensity and standard deviations
of 6 out of 10 scanned fields per slide were calculated automatically by the software. Immuno-
histochemistry (IHC) assays on sections of oviduct tissues were performed by using a polymer-
based colorimetric indirect immunoalkaline phosphatase method with a polyclonal rabbit anti-
T-cadherin antibody, as previously described [100].
Micro-RNA Analysis by microarray and real time PCR
For miRNA microarray analysis, the Signosis’miRNA Array IV service was used according to
the company’s standard procedure (Signosis, Inc. Sunnyvale, CA), as previously described
[3]. Briefly, total RNA was isolated from homogenized oviduct tissues and annealed to a bio-
tin-UTP labeled oligonucleotide probe mixture corresponding to 540 randomly selected miR-
NAs which have been reported to play a role in inflammation, apoptosis and cancer by
literature search [101]. After hybridization of biotin-UTP labeled probes, the miRNA
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expression arrays were detected by Streptavidin-HRP chemiluminescence. The chemilumi-
nescent signals were acquired using the Alpha Innotech FluorChem FC2 imaging system.
With the array assay, the expression of 540 miRNAs was profiled in the samples. Quantitative
Real-Time PCR was used to validate the microarray data for selected miRNAs based on a
minimum of two-fold increase or decrease among the experimental groups observed in the
microarrays. There was a focus on miRNAs showing a decrease or increase in the oviducts
from infected infertile mice, as compared to uninfected mice. For Real-time miRNA PCR, the
miRNA-specific oligo mix was used instead of the random oligomix. The ligated products
were eluted and mixed with miRNA specific qPCR primers and SYBR miRNA PCR buffer
mix. The Real-Time PCR was conducted on the ABI 7700 system using TaqMan Small RNA
assays (Applied Biosystems) and subjected to 35 PCR cycles: 95°C 15 seconds and 50 seconds.
The small RNA U6 was used as an internal (endogenous) control and so the relative expres-
sion of miRNAs was normalized to U6 miRNA expression. Real-time PCR data were analyzed
using the ddCT method by the standard procedure [101]. Information about miRNA target
mRNA genes was obtained from several Web-accessible miRNA database searching pro-
grams, including http://www.microrna.org, http://www.miRBase.org, http://www.targetscan.
org and published reports [102]. Experiments were repeated 4 times with at least 6 oviducts
in each group.
Proteomics Analysis
The quantitative differential proteomics with isobaric tags for relative quantitation (iTRAQ)
labeling and LC-MS analysis was used to identify proteins that were differentially expressed in
the oviducts from chlamydial infected mice, as previously described [103,104]. Briefly, proteins
were extracted from oviducts and digested with trypsin, dried and reconstituted in 0.5 M
TEAB then labeled with 4-plex iTRAQ according to the manufacturer’s AB SCIEX protocol
(Applied Biosystens Inc., ABI, Foster City, CA), using the 114, 115, 116 and 117 iTRAQ tags.
Labeled samples were pooled and subjected to a strong cation exchange and liquid chromatog-
raphy, followed by mass spectrometry (MS) analysis of eluted fractions for protein identifica-
tion and quantification. Protein/peptide identification and quantification were performed with
the Protein Pilot Software version 4.5 and MASCOT, including the search of the database for
murine or human proteins (http://www.uniprot.org). Only protein identified by at least 2 pep-
tides and with a P-value< 0.05 were used for quantitation. The biological and functional prop-
erties of the proteins and their physiological and disease pathways were established through
Elsevier software-Pathway Studio 10 (http://www.elsevier.com/online-tools/pathway-studio)
and other specialized biomedical databases that include PubMed and Medline searches.
Statistical Analysis
The data derived from different experiments were analyzed and compared by performing a
one- or two-tailed t test, and the relationship between different experimental groupings was
assessed by analysis of variance (ANOVA). Statistical significance was judged at P< 0.05.
Ethics Statement
All animal protocols were approved by the CDC Institutional Animal Care and Use Committee
(IACUC) under Protocol # 2605IGIMOUC-A1. The CDC IACUC is guided by Title 9, Chapter
I, Subchapter A—Animal Welfare (USDA Regulations).
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 20 / 26
Acknowledgments
We thank Dr. Chryssa Kanellopoulou of the NIH, Bethesda, MD for providing us anti-mouse
Dicer antisera for comparison with the commercially available anti-Dicer antibodies.
Note: The conclusions in this report are those of the author(s) and do not necessarily repre-
sent the official position of the Centers for Disease Control and Prevention/the Agency for
Toxic Substances and Disease Registry.
Author Contributions
Conceived and designed the experiments: JUI YO OS MSR JP QH KJ DE BB ZG FOE CB HL
GYW-JS JP KK CMB. Performed the experiments: JUI YO OS MSR JP QH KJ DE BB ZG FOE
CB HL GYW-JS JP KK CMB. Analyzed the data: JUI YO OS MSR JP QH KJ DE BB ZG FOE
CB HL GYW-JS JP KK CMB. Contributed reagents/materials/analysis tools: JUI YO OS MSR
JP QH KJ DE BB ZG FOE CB HL GYW-JS JP KK CMB. Wrote the paper: JUI YO OS MSR JP
QH KJ DE BB ZG FOE CB HL GYW-JS JP KK CMB.
References
1. Simonetti A, Melo J, de Souza P, Bruneska D, de Lima Filho J (2009) Immunological's host profile for
HPV andChlamydia trachomatis, a cervical cancer cofactor. Microbes Infect 11: 435–442. doi: 10.
1016/j.micinf.2009.01.004 PMID: 19397882
2. Debattista J, Timms P, Allan J (2003) Immunopathogenesis of Chlamydia trachomatis infections in
women. Fertil Steril 79: 1273–1287. PMID: 12798871
3. Igietseme JU, Omosun Y, Partin J, Goldstein J, He Q, Joseph K, et al. (2013) Prevention of Chla-
mydia-induced infertility by inhibition of local caspase activity. J Infect Dis 207: 1095–1104. doi: 10.
1093/infdis/jit009 PMID: 23303804
4. Yeruva L, Myers G, Spencer N, Creasy H, Adams N, Maurelli AT, et al. (2014) Early microRNA
expression profile as a prognostic biomarker for the development of pelvic inflammatory disease in a
mouse model of chlamydial genital infection. MBio 5: 01241–01214.
5. Gupta R, Arkatkar T, Yu J, Wali S, HaskinsWE, Chambers JP, et al. (2015) Chlamydia muridarum
Infection Associated Host MicroRNAs in the Murine Genital Tract and Contribution to Generation of
Host Immune Response. Am J Reprod Immunol 73: 126–140. doi: 10.1111/aji.12281 PMID:
24976530
6. Shyu A, Wilkinson M, van Hoof A (2008) Messenger RNA regulation: to translate or to degrade.
EMBO J 27: 471–481. doi: 10.1038/sj.emboj.7601977 PMID: 18256698
7. Lamouille S, Derynck R (2014) Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev
Mol Cell Biol 15: 178–196. doi: 10.1038/nrm3758 PMID: 24556840
8. Lee K, Nelson C (2012) New insights into the regulation of epithelial-mesenchymal transition and tis-
sue fibrosis. Int Rev Cell Mol Biol 294: 171–221. doi: 10.1016/B978-0-12-394305-7.00004-5 PMID:
22364874
9. Kothari A, Mi Z, Zapf M, Kuo P (2014) Novel clinical therapeutics targeting the epithelial to mesenchy-
mal transition. Clin Transl Med 3: 35–48. doi: 10.1186/s40169-014-0035-0 PMID: 25343018
10. Yan J, Gumireddy K, Li A, Huang Q (2013) Regulation of Mesenchymal Phenotype by MicroRNAs in
Cancer. Curr Cancer Drug Targets 13: 930–934. PMID: 24168190
11. Sweetwyne M, Murphy-Ullrich J (2012) Thrombospondin1 in tissue repair and fibrosis: TGF-b-depen-
dent and independent mechanisms. Matrix Biol 31: 178–186. doi: 10.1016/j.matbio.2012.01.006
PMID: 22266026
12. Boini K, Xia M, Xiong J, Li C, Payne LP, Li PL (2012) Implication of CD38 gene in podocyte epithelial-
to-mesenchymal transition and glomerular sclerosis. J Cell Mol Med 16: 1674–1685. doi: 10.1111/j.
1582-4934.2011.01462.x PMID: 21992601
13. Zhang S, Lin H, Kong S, Wang S, Wang H, Wang H, et al. (2013) Physiological and molecular deter-
minants of embryo implantation. Mol Aspects 34: 939–980.
14. Chen Q, Zhang Y, Elad D, Jaffa A, Cao Y, Ye X, et al. (2013) Navigating the site for embryo implanta-
tion: biomechanical and molecular regulation of intrauterine embryo distribution. Mol Aspects Med
34: 1024–1042. doi: 10.1016/j.mam.2012.07.017 PMID: 22921800
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 21 / 26
15. Wellner U, Schubert J, Burk U, Schmalhofer O, Zhu F, Sonntag A, et al. (2009) The EMT-activator
ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol 11: 1487–
1495. PMID: 19935649
16. Feng Y, Zou S, Weijdegård B, Chen J, Cong Q, Fernandez-Rodriguez J, et al. (2014) The onset of
human ectopic pregnancy demonstrates a differential expression of miRNAs and their cognate targets
in the Fallopian tube. Int J Clin Exp Pathol 7: 64–79. PMID: 24427327
17. Renjie W, Haiqian L (2015) MiR-132, miR-15a and miR-16 synergistically inhibit pituitary tumor cell
proliferation, invasion and migration by targeting Sox5. Cancer Lett 356: 568–578. doi: 10.1016/j.
canlet.2014.10.003 PMID: 25305447
18. Pei X, Lv X, Li H (2014) Sox5 induces epithelial to mesenchymal transition by transactivation of
Twist1. Biochem Biophys Res Commun 446: 322–327. doi: 10.1016/j.bbrc.2014.02.109 PMID:
24607904
19. He Y, Huang C, Lin X, Li J (2013) MicroRNA-29 family, a crucial therapeutic target for fibrosis dis-
eases. Biochimie 95: 1355–1359. doi: 10.1016/j.biochi.2013.03.010 PMID: 23542596
20. Zhang Y, Huang X-R, Wei L-H, Chung A, Yu C-M, Lan HY (2014) miR-29b as a Therapeutic Agent for
Angiotensin II-induced Cardiac Fibrosis by Targeting TGF-β/Smad3 signaling. Molecular Therapy 22:
974–985. doi: 10.1038/mt.2014.25 PMID: 24569834
21. Yu J-W, DuanW-J, Huang X-R, Meng X-M, Yu X-Q, Lan HY (2014) MicroRNA-29b inhibits peritoneal
fibrosis in a mouse model of peritoneal dialysis. Lab Invest 94: 978–990. doi: 10.1038/labinvest.2014.
91 PMID: 25046436
22. Nishikawa R, Goto Y, Kojima S, Enokida H, Chiyomaru T, Kinoshita T, et al. (2014) Tumor-suppres-
sive microRNA-29s inhibit cancer cell migration and invasion via targeting LAMC1 in prostate cancer.
Int J Oncol 45: 401–410. doi: 10.3892/ijo.2014.2437 PMID: 24820027
23. Yamamoto N, Kinoshita T, Nohata N, Yoshino H, Itesako T, Fujimura L, et al. (2013) Tumor-suppres-
sive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squa-
mous cell carcinoma. Int J Oncol 43: 1855–1863. doi: 10.3892/ijo.2013.2145 PMID: 24141696
24. Diaz-Lopez A, Moreno-Bueno G, Cano A (2014) Role of microRNA in epithelial to mesenchymal tran-
sition and metastasis and clinical perspectives. Cancer Management and Research 6: 205–216. doi:
10.2147/CMAR.S38156 PMID: 24812525
25. Renthal N, Chen C-C, Williams K, Gerard R, Prange-Kiel J, Mendelson CR (2010) mir-200 family and
targets, ZEB1 and ZEB2, modulate uterine quiescence and contratility during pregnancy and labor.
PNAS USA 107: 20828–20833. doi: 10.1073/pnas.1008301107 PMID: 21079000
26. Ma L, Young J, Prabhala H, Pan E, Mestdagh P, Muth D, et al. (2010) miR-9, a MYC/MYCN-activated
microRNA, regulates E-cadherin and cancer metastasis. Nat Cell Biol 12: 247–256. doi: 10.1038/
ncb2024 PMID: 20173740
27. Yuva-Aydemir Y, Simkin A, Gascon E, Gao F (2011) MicroRNA-9: functional evolution of a conserved
small regulatory RNA. RNA Biol 8: 557–564. doi: 10.4161/rna.8.4.16019 PMID: 21697652
28. Song S, Ito K, Ala U, Kats L, Webster K, Sun SM, et al. (2013) The oncogenic microRNAmiR-22 tar-
gets the TET2 tumor suppressor to promote hematopoietic stem cell self-renewal and transformation.
Cell Stem Cell 13: 87–101. doi: 10.1016/j.stem.2013.06.003 PMID: 23827711
29. Song S, Pandoldi P (2014) miR-22 in tumorigenesis. Cell Cycle 13: 11–12. doi: 10.4161/cc.27027
PMID: 24231768
30. Kramann R, DiRocco D, Humphreys B (2013) Understanding the origin, activation and regulation of
matrix-producing myofibroblasts for treatment of fibrotic disease. J Pathol 231: 273–289. doi: 10.
1002/path.4253 PMID: 24006178
31. Xiong G, Zhang Y, Han B, ChenW, Yang Y, Peng JP (2011) Estradiol-regulated proline-rich acid pro-
tein 1 is repressed by class I histone deacetylase and functions in peri-implantation mouse uterus.
Mol Cell Endocrinol 331: 23–33. doi: 10.1016/j.mce.2010.06.003 PMID: 20547205
32. Kawahara H, Minami R, Yokota N (2013) BAG6/BAT3: emerging roles in quality control fot nascent
polypeptides. J Biochem 153: 147–160. doi: 10.1093/jb/mvs149 PMID: 23275523
33. Shi Z, Wei Q, Zhang M, She J (2014) MicroRNAs in bladder cancer: expression profiles, biological
functions, regulation, and clinical implications. Crit Rev Eukaryot Gene Expr 24: 55–75. PMID:
24579670
34. Elgamal O, Park J, Gusev Y, Azevedo-Pouly A, Jiang J, Roopra A, et al. (2013) Tumor suppressive
function of mir-205 in breast cancer is linked to HMGB3 regulation. PLoS One 8: e76402. doi: 10.
1371/journal.pone.0076402 PMID: 24098490
35. Fang Z, Luna E (2013) Supervillin-mediated suppression of p53 protein enhances cell survival. J Biol
Chem 288: 7918–7929. doi: 10.1074/jbc.M112.416842 PMID: 23382381
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 22 / 26
36. Crowley JL S T, Fang Z, Takizawa N, Luna EJ. (2009) Supervillin reorganizes the actin cytoskeleton
and increases invadopodial efficiency. Mol Biol Cell 20: 948–962. doi: 10.1091/mbc.E08-08-0867
PMID: 19109420
37. Ren L, Liu Y, Guo L, Wang H, Ma L, Zeng M, et al. (2013) Loss of Smu1 function de-represses DNA
replication and over-activates ATR-dependent replication checkpoint. Biochem Biophys Res Com-
mun 436: 192–198. doi: 10.1016/j.bbrc.2013.05.072 PMID: 23727573
38. Herrero A, Moreno S (2011) Lsm1 promotes genomic stability by controlling histone mRNA decay.
EMBO J 30: 2008–2018. doi: 10.1038/emboj.2011.117 PMID: 21487390
39. Streicher K, Yang Z, Draghici S, SP E (2007) Transforming function of the LSM1 oncogene in human
breast cancers with the 8p11-12 amplicon. Oncogene 26: 2104–2114. PMID: 17001308
40. Zarnescua D, Gregoriob C (2013) Fragile hearts: New insights into translational control in cardiac
muscle. Trends Cardiovasc Med 23: 275–281. doi: 10.1016/j.tcm.2013.03.003 PMID: 23582851
41. Byrne A, McLaren R, Mason P, Chai L, Dufault M, Huang Y, et al. (2010) Knockdown of human deubi-
quitinase PSMD14 induces cell cycle arrest and senescence. Exp Cell Res 316: 258–271. doi: 10.
1016/j.yexcr.2009.08.018 PMID: 19732767
42. Lykke-Andersen K, Schaefer L, Menon S, Deng X, Miller JB, Wei N (2003) Disruption of the COP9 sig-
nalosome Csn2 subunit in mice causes deficient cell proliferation, accumulation of p53 and cyclin E,
and early embryonic death. Mol Cell Biol 23: 6790–6797. PMID: 12972599
43. Zhang S, Pei D, Zheng J (2013) COP9 signalosome subunit 6 (CSN6): a potential oncogene. Cell Div
8: 14–18. doi: 10.1186/1747-1028-8-14 PMID: 24286178
44. Lee M, Zhao R, Phan L, Yeung S (2011) Role of COP9 signalosome in cancer. Cell cycle 10: 3057–
3066. PMID: 21876386
45. Kiyamova R, Garifulin O, Gryshkova V, Kostianets O, Shyian M, Gout I, et al. (2012) Preliminary study
of thyroid and colon cancers-associated antigens and their cognate autoantibodies as potential can-
cer biomarkers. Biomarkers 17: 362–371. doi: 10.3109/1354750X.2012.677476 PMID: 22612312
46. Huang Q, Zhou H, Zhang H, Huang Y, Hinojosa-Kirschenbaum F, Fan P, et al. (2015) Thioredoxin-2
inhibits mitochondrial reactive oxygen species generation and apoptosis stress kinase-1 activity to
maintain cardiac function. Circulation 131: 1082–1097. doi: 10.1161/CIRCULATIONAHA.114.
012725 PMID: 25628390
47. Ashida H, Maeda Y, K T. (2006) DPM1, the catalytic subunit of dolichol-phosphate mannose
synthase, is tethered to and stabilized on the endoplasmic reticulummembrane by DPM3. J Biol
Chem 281: 896–904. PMID: 16280320
48. Shen Y, Song G, Liu Y, Zhou L, Liu H, Kong X, et al. (2013) Silencing of FABP3 inhibits proliferation
and promotes apoptosis in embryonic carcinoma cells. Cell Biochem Biophys 66: 139–146. doi: 10.
1007/s12013-012-9462-y PMID: 23097025
49. Yu J, Wu J, Bagchi I, Bagchi M, Sidell N, Taylor RN (2011) Disruption of gap junctions reduces bio-
markers of decidualization and angiogenesis and increases inflammatory mediators in human endo-
metrial stromal cell cultures. Mol Cell Endocrinol 344: 25–34. doi: 10.1016/j.mce.2011.04.011 PMID:
21767601
50. Laws M, Taylor R, Sidell N, DeMayo F, Lydon JP, Gutstein DE, et al. (2008) Gap junction communica-
tion between uterine stromal cells plays a critical role in pregnancy-associated neovascularization
and embryo survival. Development 135: 2659–2668. doi: 10.1242/dev.019810 PMID: 18599509
51. Yu J, Boicea A, Barrett K, James C, Bagchi I, Bagchi MK, et al. (2014) Reduced connexin 43 in euto-
pic endometrium and cultured endometrial stromal cells from subjects with endometriosis. Mol Hum
Reprod 20: 260–270. doi: 10.1093/molehr/gat087 PMID: 24270393
52. Castellano P, Eugenin E (2014) Regulation of gap junction channels by infectious agents and inflam-
mation in the CNS. Front Cell Neurosci 8: 122 (121–110). doi: 10.3389/fncel.2014.00122 PMID:
24847208
53. Prins J, Gomez-Lopez N, Robertson S (2012) Interleukin-6 in pregnancy and gestational disorders. J
Reprod Immunol 95: 1–14. doi: 10.1016/j.jri.2012.05.004 PMID: 22819759
54. Yun U, Park S, Jo Y, Kim J, DY S (2012) DNA damage induces the IL-6/STAT3 signaling pathway,
which has anti-senescence and growth-promoting functions in human tumors. Cancer Lett 323: 155–
160. doi: 10.1016/j.canlet.2012.04.003 PMID: 22521547
55. Catalano R, Johnson M, Campbell E, Charnock-Jones D, Smith SK, Sharkey AM (2005) Inhibition of
Stat3 activation in the endometrium prevents implantation: a nonsteroidal approach to contraception.
Proc Natl Acad Sci U S A 102: 8585–8590. PMID: 15937114
56. Butterworth M, Edinger R, Ovaa H, Burg D, Johnson JP, Frizzell RA (2007) The deubiquitinating
enzyme UCH-L3 regulates the apical membrane recycling of the epithelial sodium channel. J Biol
Chem 282: 37885–37893. PMID: 17967898
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 23 / 26
57. Mtango N, Latham K, Sutovsky P (2014) Deubiquitinating enzymes in oocyte maturation, fertilization
and preimplantation embryo development. Adv Exp Med Biol 759: 89–110. doi: 10.1007/978-1-4939-
0817-2_5 PMID: 25030761
58. Friso S, Carvajal C, Fardella C, Olivieri O (2015) Epigenetics and arterial hypertension: the challenge
of emerging evidence. Transl Res 165: 154–165. doi: 10.1016/j.trsl.2014.06.007 PMID: 25035152
59. Moore R, Cai K, TaoW, Smith E, Xu X-X (2013) Differential requirement for Dab2 in the development
of embryonic and extra-embryonic tissues. BMCDev Biol 13: 39. doi: 10.1186/1471-213X-13-39
PMID: 24168030
60. Yang D, Cai K, Roland I, Smith E, Xu X (2007) Disabled-2 is an epithelial surface positioning gene. J
Biol Chem 282: 13114–13122. PMID: 17339320
61. Zhang Z, Chen Y, Tang J, Xie X (2014) Frequent loss expression of dab2 and promotor hypermethyla-
tion in human cancers: a meta-analysis and systematic review. Pak J Med Sci 30: 432–437. PMID:
24772157
62. Rylski M, Amborska R, Zybura K, Mioduszewska B, Michaluk P, Jaworski J, et al. (2008) Yin Yang 1
is a critical repressor of matrix metalloproteinase-9 expression in brain neurons. J Biol Chem 283:
35140–35153. doi: 10.1074/jbc.M804540200 PMID: 18940814
63. Chinnadurai G (2009) The transcriptional corepressor CtBP: a foe of multiple tumor suppressors.
Cancer Res 69: 731–734. doi: 10.1158/0008-5472.CAN-08-3349 PMID: 19155295
64. Zhang C, Jiang H, Chang Y, Fang Z, Sun XE, Liu JS, et al. (2009) Downregulation of CD2-associated
protein impaired the physiological functions of podocytes. Cell Biol Int 33: 632–639. doi: 10.1016/j.
cellbi.2009.02.017 PMID: 19306938
65. Citi S, Guerrera D, Spadaro D, Shah J (2014) Epithelial junctions and Rho family GTPases: the zonu-
lar signalosome. Small GTPases 5: 1–15.
66. Veresov V, Davidovskii A (2014) Structural insights into proapoptotic signaling mediated by MTCH2,
VDAC2, TOM40 and TOM22. Cell Signal 26: 370–382. doi: 10.1016/j.cellsig.2013.11.016 PMID:
24269536
67. Arigoni M, Barutello G, Riccardo F, Ercole E, Cantarella D, Orso F, et al. (2013) miR-135b coordinates
progression of ErbB2-driven mammary carcinomas through suppression of MID1 and MTCH2. Am J
Pathol 182: 2058–2070. doi: 10.1016/j.ajpath.2013.02.046 PMID: 23623609
68. Kim B, Dong S, Seo S, Lee JH, Lee JM, Lee SH, et al. (2014) Lysyl oxidase-like 2 (LOXL2) controls
tumor-associated cell proliferation through the interaction with MARCKSL1. Cell Signal 26: 1765–
1773. doi: 10.1016/j.cellsig.2014.05.010 PMID: 24863880
69. Liu Y, Marks K, Cowley G, Carretero J, Liu Q, Nieland TJ, et al. (2013) Metabolic and Functional
Genomic Studies Identify Deoxythymidylate Kinase as a target in LKB1 Mutant Lung Cancer. Cancer
Discov 3: 870–879. doi: 10.1158/2159-8290.CD-13-0015 PMID: 23715154
70. Lin W, Zhu C, Hong J, Zhao L, Jilg N, Fusco DN, et al. (2015) The spliceosome factor SART1 exerts
its anti-HCV action through mRNA splicing. J Hepatol 62: 1024–1032. doi: 10.1016/j.jhep.2014.11.
038 PMID: 25481564
71. Kang H, Escudero-Esparza A, Douglas-Jones A, Mansel R, JiangW (2009) Transcript analyses of
stromal cell derived factors (SDFs): SDF-2, SDF-4 and SDF-5 reveal a different pattern of expression
and prognostic association in human breast cancer. Int J Oncol 35: 205–211. PMID: 19513569
72. Feng Z, Tang L, Wu L, Cui S, Hong Q, et al. (2014) Na+/H+ exchanger-1 reduces podocyte injury
caused by endoplasmic reticulum stress via autophagy activation. Lab Invest 94: 439–454. doi: 10.
1038/labinvest.2014.4 PMID: 24566932
73. Christianson M, Yates M (2012) Scavenger receptor class B type 1 gene polymorphisms and female
fertility. Curr Opin Endocrinol Diabetes Obes 19: 115–120. doi: 10.1097/MED.0b013e3283505771
PMID: 22261999
74. DeAngelis A, Roy-O'Reilly M, Rodriguez A (2014) Genetic alterations affecting cholesterol metabo-
lism and human fertility. Biol Reprod 91: 117. doi: 10.1095/biolreprod.114.119883 PMID: 25122065
75. Kim T, Hempstead B (2009) NRH2 is a trafficking switch to regulate sortilin localization and permit pro-
neurotrophin-induced cell death. EMBO J 28: 1612–1623. doi: 10.1038/emboj.2009.118 PMID:
19407813
76. Igietseme JU, He Q, Joseph K, Eko F, Lyn D, Ananaba G, et al. (2009) Role of T lymphocytes in the
pathogenesis of Chlamydia disease. J Infect Dis 200: 926–934. doi: 10.1086/605411 PMID:
19656067
77. Murthy AK, Li W, Chaganty BK, Kamalakaran S, Guentzel MN, Seshu J, et al. (2011) Tumor necrosis
factor alpha production from CD8+ T cells mediates oviduct pathological sequelae following primary
genital Chlamydia muridarum infection. Infect Immun 79: 2928–2935. doi: 10.1128/IAI.05022-11
PMID: 21536799
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 24 / 26
78. Darville T, Hiltke T (2010) Darville T, Hiltke TJ. Pathogenesis of genital tract disease due to Chlamydia
trachomatis. J Infect Dis. 2010; 201(Suppl 2):S114–125. J Infect Dis 201: S114–125. PMID:
20524234
79. Nothnick W (2012) The role of micro-RNAs in the female reproductive tract. Reproduction 143: 559–
576. doi: 10.1530/REP-11-0240 PMID: 22454533
80. Song S, Poliseno L, Song M, Ala U, Webster K, Ng C, et al. (2013) MicroRNA-antagonism regulates
breast cancer stemness and metastasis via TET-family-dependent chromatin remodeling. Cell 154:
311–324. doi: 10.1016/j.cell.2013.06.026 PMID: 23830207
81. Takahashi R-U, Miyazaki H, Ochiya T (2014) The role of microRNAs in the regulation of cancer. Front
Genet 4: 295 (291–211). doi: 10.3389/fgene.2013.00295 PMID: 24427168
82. Rubina K, Surkova E, Semina E, Sysoeva V, Kalinina N, Poliakov AA, et al. (2015) T-Cadherin
Expression in Melanoma Cells Stimulates Stromal Cell Recruitment and Invasion by Regulating the
Expression of Chemokines, Integrins and Adhesion Molecules. Cancers (Basel) 7: 1349–1370.
83. Ramón L, Braza-Boïls A, Gilabert J, Chirivella M, España F, Estelles A, et al. (2012) microRNAs
related to angiogenesis are dysregulated in endometrioid endometrial cancer. Hum Reprod 27:
3036–3045. doi: 10.1093/humrep/des292 PMID: 22904162
84. Jayachandran A, Anaka M, Prithviraj P, Hudson C, McKeown S, Lo PH, et al. (2014) Thrombospondin
1 promotes an aggressive phenotype through epithelial-to-mesenchymal transition in humanmela-
noma. Oncotarget 5: 5782–5797. PMID: 25051363
85. Bujak E, Pretto F, Ritz D, Gualandi L, Wulhfard S, Neri D (2014) Monoclonal antibodies to murine
thrombospondin-1 and thrombospondin-2 reveal differential expression patterns in cancer and low
antigen expression in normal tissues. Exp Cell Res 327: 135–145. doi: 10.1016/j.yexcr.2014.05.024
PMID: 24925479
86. Oikonomou N, Harokopos V, Zalevsky J, Valavanis C, Kotanidou A, Szymkowski DE, et al. (2006)
Soluble TNFmediates the transition from pulmonary inflammation to fibrosis. PLoS One 1: e108.
PMID: 17205112
87. Jiménez-Salazar J, Posadas-Rodríguez P, Lazzarini-Lechuga R, Luna-López A, Zentella-Dehesa A,
Gomez-Quiroz LE, et al. (2014) Membrane-initiated estradiol signaling of epithelial-mesenchymal
transition-associated mechanisms through regulation of tight junctions in human breast cancer cells.
Horm Cancer 5: 161–173. doi: 10.1007/s12672-014-0180-3 PMID: 24771004
88. Cano A, Santamaría P, Moreno-Bueno G (2012) LOXL2 in epithelial cell plasticity and tumor progres-
sion. Future Oncol 8: 1095–1108. doi: 10.2217/fon.12.105 PMID: 23030485
89. Moon H, Finney J, Ronnebaum T, Mure M (2014) Human lysyl oxidase-like 2. Bioorg Chem 57: 231–
241. doi: 10.1016/j.bioorg.2014.07.003 PMID: 25146937
90. Jonsdottir K, Zhang H, Jhagroe D, Skaland I, Slewa A, Bjorkblom B, et al. (2012) The prognostic value
of MARCKS-like 1 in lymph node-negative breast cancer. Breast Cancer Res Treat 135: 381–390.
doi: 10.1007/s10549-012-2155-9 PMID: 22772381
91. Shao R, Shi J, Liu H, Shi X, Du X, Klocker H, et al. (2014) Epithelial-to-mesenchymal transition and
estrogen receptor αmediated epithelial dedifferentiation mark the development of benign prostatic
hyperplasia. Prostate 74: 970–982. doi: 10.1002/pros.22814 PMID: 24752964
92. Schiffman M, Wentzensen N, Wacholder S, KinneyW, Gage JC, Castle PE (2011) Human papilloma-
virus testing in the prevention of cervical cancer. J Natl Cancer Inst 103: 368–383. doi: 10.1093/jnci/
djq562 PMID: 21282563
93. Mühlen S, Behren A, Iftner T, Simon C (2010) Influence of HPV16 E2 and its localisation on the
expression of matrix metallopro-teinase-9. Int J Oncol 37: 337–345. PMID: 20596661
94. Arbeit J, Howley P, Hanahan D (1996) Chronic estrogen-induced cervical and vaginal squamous car-
cinogenesis in human papillomavirus type 16 transgenic mice. Proc Natl Acad Sci U S A 93: 2930–
2935. PMID: 8610145
95. Brake T, Lambert P (2005) Estrogen contributes to the onset, persistence, and malignant progression
of cervical cancer in a human papillomavirus-transgenic mouse model. Proc Natl Acad Sci U S A 102:
2490–2495. PMID: 15699322
96. Grange C, Collino F, Tapparo M, Camussi G (2014) Oncogenic micro-RNAs and renal cell carcinoma.
Frontiers in Oncology 4: 1–10.
97. Tuffrey M, Taylor-Robinson D (1981) Progesterone as a key factor in the development of a mouse
model for genital-tract infection with Chlamydia trachomatis. FEMSMicrobiolLet 12: 111–115.
98. Tuffrey M, Alexander F, Woods C, Taylor-Robinson D (1992) Genetic susceptibility to chlamydial sal-
pingitis and subsequent infertility in mice. JReprodFertil 95: 31–38.
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 25 / 26
99. Pal S, Hui W, Peterson EM, de la Maza LM (1998) Factors influencing the induction of infertility in a
mouse model of Chlamydia trachomatis ascending genital infection. J Med Microbiol 47: 599–605.
PMID: 9839564
100. ShiehW, Blau D, Denison A, Deleon-Carnes M, Adem P, Bhatnagar J, et al. (2010) 2009 pandemic
influenza A (H1N1): pathology and pathogenesis of 100 fatal cases in the United States. Am J Pathol
177: 166–175. PMID: 20508031
101. Chang CC, Zhang QY, Liu Z, Clynes RA, Suciu-Foca N, Vlad G (2012) Downregulation of inflamma-
tory microRNAs by Ig-like transcript 3 is essential for the differentiation of human CD8(+) T suppressor
cells. J Immunol 188: 3042–3052. doi: 10.4049/jimmunol.1102899 PMID: 22387553
102. Nagaraja A, Andreu-Vieyra C, Franco H, Ma L, Chen R, Han DY, et al. (2008) Deletion of Dicer in
somatic cells of the female reproductive tract causes sterility. Mol Endocrinol 22: 2336–2352. doi: 10.
1210/me.2008-0142 PMID: 18687735
103. Légaré C, Droit A, Fournier F, Bourassa S, Force A, Cloutier F, et al. (2014) Investigation of Male Infer-
tility Using Quantitative Comparative Proteomics. J Proteome Res 13: 5403–5414. doi: 10.1021/
pr501031x PMID: 25355644
104. Su L, Cao L, Zhou R, Jiang Z, Xiao K, KongW, et al. (2013) Identification of novel biomarkers for sep-
sis prognosis via urinary proteomic analysis using iTRAQ labeling and 2D-LC-MS/MS. PLoS One 8:
e54237. doi: 10.1371/journal.pone.0054237 PMID: 23372690
105. Havelange V, Ranganathan P, Geyer S, Nicolet D, Huang X, Yu X, et al. (2014) Implications of the
miR-10 family in chemotherapy response of NPM1-mutated AML. Blood 123: 2412–2415. doi: 10.
1182/blood-2013-10-532374 PMID: 24596420
Chlamydia Induces Epithelial-Mesenchyme Transition (EMT)
PLOS ONE | DOI:10.1371/journal.pone.0145198 December 17, 2015 26 / 26
